Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers.

Olsen SN, Wronski A, Castaño Z, Dake B, Malone C, De Raedt T, Enos M, DeRose YS, Zhou W, Guerra S, Loda M, Welm A, Partridge AH, McAllister SS, Kuperwasser C, Cichowski K.

Cancer Discov. 2017 Feb;7(2):202-217. doi: 10.1158/2159-8290.CD-16-0520. Epub 2016 Dec 14.

2.

Cardiovascular, metabolic, and coronary dysfunction in high-fat-fed obesity-resistant/prone rats.

Dake BL, Oltman CL.

Obesity (Silver Spring). 2015 Mar;23(3):623-9. doi: 10.1002/oby.21009. Epub 2015 Feb 3.

3.

Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley rat: a new animal model for type 2 diabetes.

Davidson EP, Coppey LJ, Holmes A, Lupachyk S, Dake BL, Oltman CL, Peterson RG, Yorek MA.

J Diabetes Res. 2014;2014:714273. doi: 10.1155/2014/714273. Epub 2014 Oct 13.

4.

NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.

Kottakis F, Foltopoulou P, Sanidas I, Keller P, Wronski A, Dake BT, Ezell SA, Shen Z, Naber SP, Hinds PW, McNiel E, Kuperwasser C, Tsichlis PN.

Cancer Res. 2014 Jul 15;74(14):3935-46. doi: 10.1158/0008-5472.CAN-13-2733. Epub 2014 May 22.

5.

Assessment of elastin deficit in a Marfan mouse aneurysm model using an elastin-specific magnetic resonance imaging contrast agent.

Okamura H, Pisani LJ, Dalal AR, Emrich F, Dake BA, Arakawa M, Onthank DC, Cesati RR, Robinson SP, Milanesi M, Kotek G, Smit H, Connolly AJ, Adachi H, McConnell MV, Fischbein MP.

Circ Cardiovasc Imaging. 2014 Jul;7(4):690-6. doi: 10.1161/CIRCIMAGING.114.001658. Epub 2014 May 9.

PMID:
24814820
6.

Identification of a unique TGF-β-dependent molecular and functional signature in microglia.

Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL.

Nat Neurosci. 2014 Jan;17(1):131-43. doi: 10.1038/nn.3599. Epub 2013 Dec 8. Erratum in: Nat Neurosci. 2014 Sep;17(9):1286.

7.

The RasGAP gene, RASAL2, is a tumor and metastasis suppressor.

McLaughlin SK, Olsen SN, Dake B, De Raedt T, Lim E, Bronson RT, Beroukhim R, Polyak K, Brown M, Kuperwasser C, Cichowski K.

Cancer Cell. 2013 Sep 9;24(3):365-78. doi: 10.1016/j.ccr.2013.08.004.

8.

Using defined finger-finger interfaces as units of assembly for constructing zinc-finger nucleases.

Zhu C, Gupta A, Hall VL, Rayla AL, Christensen RG, Dake B, Lakshmanan A, Kuperwasser C, Stormo GD, Wolfe SA.

Nucleic Acids Res. 2013 Feb 1;41(4):2455-65. doi: 10.1093/nar/gks1357. Epub 2013 Jan 8.

9.

Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.

Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, Gali RR, Iyer LK, Lawson R, Berry J, Krichevsky AM, Cudkowicz ME, Weiner HL.

J Clin Invest. 2012 Sep;122(9):3063-87. doi: 10.1172/JCI62636. Epub 2012 Aug 6.

10.

miR-29b participates in early aneurysm development in Marfan syndrome.

Merk DR, Chin JT, Dake BA, Maegdefessel L, Miller MO, Kimura N, Tsao PS, Iosef C, Berry GJ, Mohr FW, Spin JM, Alvira CM, Robbins RC, Fischbein MP.

Circ Res. 2012 Jan 20;110(2):312-24. doi: 10.1161/CIRCRESAHA.111.253740. Epub 2011 Nov 23.

PMID:
22116819
11.

In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling.

Wu HY, Quintana FJ, da Cunha AP, Dake BT, Koeglsperger T, Starossom SC, Weiner HL.

PLoS One. 2011;6(8):e23618. doi: 10.1371/journal.pone.0023618. Epub 2011 Aug 23.

12.

Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.

Davidson EP, Coppey LJ, Dake B, Yorek MA.

Exp Diabetes Res. 2011;2011:810469. doi: 10.1155/2011/810469. Epub 2011 Jul 21.

13.

Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.

Davidson EP, Coppey LJ, Holmes A, Dake B, Yorek MA.

Eur J Pharmacol. 2011 Oct 15;668(3):497-506. doi: 10.1016/j.ejphar.2011.07.016. Epub 2011 Jul 28.

14.

Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.

Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Dake B, Yorek MA.

Eur J Pharmacol. 2011 Jan 15;650(2-3):556-62. doi: 10.1016/j.ejphar.2010.10.047. Epub 2010 Oct 30.

15.

Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity.

Davidson EP, Coppey LJ, Dake B, Yorek MA.

J Obes. 2011;2011. pii: 686952. doi: 10.1155/2011/686952. Epub 2010 Aug 16.

16.

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells.

Gandhi R, Kumar D, Burns EJ, Nadeau M, Dake B, Laroni A, Kozoriz D, Weiner HL, Quintana FJ.

Nat Immunol. 2010 Sep;11(9):846-53. doi: 10.1038/ni.1915. Epub 2010 Aug 1.

17.

Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells.

Fink BD, O'Malley Y, Dake BL, Ross NC, Prisinzano TE, Sivitz WI.

PLoS One. 2009;4(1):e4250. doi: 10.1371/journal.pone.0004250. Epub 2009 Jan 22.

18.
19.

IGF-I and IGFBP-3 transport in the rat heart.

Boes M, Dake BL, Booth BA, Sandra A, Bateman M, Knudtson KL, Bar RS.

Am J Physiol Endocrinol Metab. 2003 Jan;284(1):E237-9.

20.

Structure-function relationships of insulin-like growth factor binding protein 6 (IGFBP-6) and its chimeras.

Boes M, Dake BL, Booth BA, Sandra A, Bateman M, Knudtson K, Bar RS.

Growth Horm IGF Res. 2002 Apr;12(2):91-8.

PMID:
12175646
21.

IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis.

Booth BA, Boes M, Dake BL, Knudtson KL, Bar RS.

Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E52-8.

22.

Distribution of chimeric IGF binding protein (IGFBP)-3 and IGFBP-4 in the rat heart: importance of C-terminal basic region.

Knudtson KL, Boes M, Sandra A, Dake BL, Booth BA, Bar RS.

Endocrinology. 2001 Sep;142(9):3749-55.

PMID:
11517150
23.

Effect of IGFBP-derived peptides on incorporation of(35)SO(4)into proteoglycans.

Booth BA, Boes M, Dake BL, Caldwell EE, Weiler JM, Bar RS.

Growth Horm IGF Res. 2000 Aug;10(4):224-9.

PMID:
11032706
24.

Regulations of IGF binding proteins in human aorta vascular smooth muscle cells by cAMP, dexamethasone and IGF-I.

Hayford K, Boes M, Dake BL, Bar RS.

Growth Horm IGF Res. 1998 Oct;8(5):369-75.

PMID:
10984297
25.

Connective tissue growth factor (IGFBP-rP2) expression and regulation in cultured bovine endothelial cells.

Boes M, Dake BL, Booth BA, Erondu NE, Oh Y, Hwa V, Rosenfeld R, Bar RS.

Endocrinology. 1999 Apr;140(4):1575-80.

PMID:
10098490
27.

Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3.

Booth BA, Boes M, Dake BL, Bar RS.

Am J Physiol. 1999 Mar;276(3):E450-4. doi: 10.1152/ajpendo.1999.276.3.E450.

PMID:
10070009
28.

Infused IGF-I/IGFBP-3 complex causes glomerular localization of IGF-I in the rat kidney.

Sandra A, Boes M, Dake BL, Stokes JB, Bar RS.

Am J Physiol. 1998 Jul;275(1):E32-7. doi: 10.1152/ajpendo.1998.275.1.E32.

PMID:
9688871
29.

Bovine insulin-like growth factor binding protein-3: organization of the chromosomal gene and functional analysis of its promoter.

Erondu NE, Toland B, Boes M, Dake B, Moser DR, Bar RS.

Endocrinology. 1997 Jul;138(7):2856-62.

PMID:
9202228
30.

Structure-function relationships in the heparin-binding C-terminal region of insulin-like growth factor binding protein-3.

Booth BA, Boes M, Dake BL, Linhardt RJ, Caldwell EE, Weiler JM, Bar RS.

Growth Regul. 1996 Dec;6(4):206-13.

PMID:
8971549
32.

Regulation of endothelial IGFBP-3 synthesis and secretion by IGF-I and TGF-beta.

Erondu NE, Dake BL, Moser DR, Lin M, Boes M, Bar RS.

Growth Regul. 1996 Mar;6(1):1-9.

PMID:
8717444
33.

IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.

Booth BA, Boes M, Andress DL, Dake BL, Kiefer MC, Maack C, Linhardt RJ, Bar K, Caldwell EE, Weiler J, et al.

Growth Regul. 1995 Mar;5(1):1-17.

PMID:
7538367
34.

Endothelial cells express insulin-like growth factor-binding proteins 2 to 6.

Moser DR, Lowe WL Jr, Dake BL, Booth BA, Boes M, Clemmons DR, Bar RS.

Mol Endocrinol. 1992 Nov;6(11):1805-14.

PMID:
1282670
35.
36.

Interactions of cultured endothelial cells with TGF-beta, bFGF, PDGF and IGF-I.

Boes M, Dake BL, Bar RS.

Life Sci. 1991;48(8):811-21.

PMID:
1994187
37.

Tissue localization of perfused endothelial cell IGF binding protein is markedly altered by association with IGF-I.

Bar RS, Boes M, Dake BL, Sandra A, Bayne M, Cascieri M, Booth BA.

Endocrinology. 1990 Dec;127(6):3243-5.

PMID:
2174349
38.

Intrinsic bioactivity of insulin-like growth factor-binding proteins from vascular endothelial cells.

Booth BA, Bar RS, Boes M, Dake BL, Bayne M, Cascieri M.

Endocrinology. 1990 Dec;127(6):2630-8.

PMID:
2174333
39.

Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart.

Bar RS, Clemmons DR, Boes M, Busby WH, Booth BA, Dake BL, Sandra A.

Endocrinology. 1990 Sep;127(3):1078-86.

PMID:
1696879
40.

Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart.

Bar RS, Boes M, Clemmons DR, Busby WH, Sandra A, Dake BL, Booth BA.

Endocrinology. 1990 Jul;127(1):497-9.

PMID:
1694498
41.
42.

The effects of platelet-derived growth factor in cultured microvessel endothelial cells.

Bar RS, Boes M, Booth BA, Dake BL, Henley S, Hart MN.

Endocrinology. 1989 Apr;124(4):1841-8.

PMID:
2924726
43.

Insulin, insulin-like growth factors, and vascular endothelium.

Bar RS, Boes M, Dake BL, Booth BA, Henley SA, Sandra A.

Am J Med. 1988 Nov 28;85(5A):59-70. Review.

PMID:
2973748
44.
45.

Production of IGF-binding proteins by vascular endothelial cells.

Bar RS, Harrison LC, Baxter RC, Boes M, Dake BL, Booth B, Cox A.

Biochem Biophys Res Commun. 1987 Oct 29;148(2):734-9.

PMID:
2961328
46.

Stimulation of proteoglycans by IGF I and II in microvessel and large vessel endothelial cells.

Bar RS, Dake BL, Stueck S.

Am J Physiol. 1987 Jul;253(1 Pt 1):E21-7.

PMID:
3300363
47.
48.
49.

Multiplication-stimulating activity (MSA) stimulates proteoglycan synthesis in cultured endothelial cells.

Bar RS, Stueck S, Dake B, Spanheimer R.

Endocrinology. 1984 Dec;115(6):2487-9.

PMID:
6389097

Supplemental Content

Support Center